Hirota Y - Search Results

1

⁶⁴Cu-ATSM Predicts Efficacy of Carbon Ion Radiotherapy Associated with Cellular Antioxidant Capacity.

Nachankar A, Oike T, Hanaoka H, Kanai A, Sato H, Yoshida Y, Obinata H, Sakai M, Osu N, Hirota Y, Takahashi A, Shibata A, Ohno T. Nachankar A, et al. Among authors: hirota y. Cancers (Basel). 2021 Dec 7;13(24):6159. doi: 10.3390/cancers13246159. Cancers (Basel). 2021. PMID: 34944777 Free PMC article.

2

The EGFR mutation status affects the relative biological effectiveness of carbon-ion beams in non-small cell lung carcinoma cells.

Amornwichet N, Oike T, Shibata A, Nirodi CS, Ogiwara H, Makino H, Kimura Y, Hirota Y, Isono M, Yoshida Y, Ohno T, Kohno T, Nakano T. Amornwichet N, et al. Among authors: hirota y. Sci Rep. 2015 Jun 11;5:11305. doi: 10.1038/srep11305. Sci Rep. 2015. PMID: 26065573 Free PMC article.

3

Mitotic catastrophe is a putative mechanism underlying the weak correlation between sensitivity to carbon ions and cisplatin.

Kobayashi D, Oike T, Shibata A, Niimi A, Kubota Y, Sakai M, Amornwhichet N, Yoshimoto Y, Hagiwara Y, Kimura Y, Hirota Y, Sato H, Isono M, Yoshida Y, Kohno T, Ohno T, Nakano T. Kobayashi D, et al. Among authors: hirota y. Sci Rep. 2017 Jan 16;7:40588. doi: 10.1038/srep40588. Sci Rep. 2017. PMID: 28091564 Free PMC article.

4

FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy.

Darwis NDM, Nachankar A, Sasaki Y, Matsui T, Noda SE, Murata K, Tamaki T, Ando K, Okonogi N, Shiba S, Irie D, Kaminuma T, Kumazawa T, Anakura M, Yamashita S, Hirakawa T, Kakoti S, Hirota Y, Tokino T, Iwase A, Ohno T, Shibata A, Oike T, Nakano T. Darwis NDM, et al. Among authors: hirota y. Int J Mol Sci. 2019 Sep 14;20(18):4563. doi: 10.3390/ijms20184563. Int J Mol Sci. 2019. PMID: 31540114 Free PMC article.

5

Relative Biological Effectiveness of Carbon Ions for Head-and-Neck Squamous Cell Carcinomas According to Human Papillomavirus Status.

Osu N, Kobayashi D, Shirai K, Musha A, Sato H, Hirota Y, Shibata A, Oike T, Ohno T. Osu N, et al. Among authors: hirota y. J Pers Med. 2020 Jul 25;10(3):71. doi: 10.3390/jpm10030071. J Pers Med. 2020. PMID: 32722522 Free PMC article.

6

Radiosensitivity Differences between EGFR Mutant and Wild-Type Lung Cancer Cells are Larger at Lower Doses.

Anakura M, Nachankar A, Kobayashi D, Amornwichet N, Hirota Y, Shibata A, Oike T, Nakano T. Anakura M, et al. Among authors: hirota y. Int J Mol Sci. 2019 Jul 25;20(15):3635. doi: 10.3390/ijms20153635. Int J Mol Sci. 2019. PMID: 31349558 Free PMC article.

7

Induction of Micronuclei in Cervical Cancer Treated with Radiotherapy.

Kobayashi D, Oike T, Murata K, Irie D, Hirota Y, Sato H, Shibata A, Ohno T. Kobayashi D, et al. Among authors: hirota y. J Pers Med. 2020 Sep 3;10(3):110. doi: 10.3390/jpm10030110. J Pers Med. 2020. PMID: 32899112 Free PMC article.

8

Comparison of Clonogenic Survival Data Obtained by Pre- and Post-Irradiation Methods.

Oike T, Hirota Y, Dewi Maulany Darwis N, Shibata A, Ohno T. Oike T, et al. Among authors: hirota y. J Pers Med. 2020 Oct 15;10(4):171. doi: 10.3390/jpm10040171. J Pers Med. 2020. PMID: 33076277 Free PMC article.

9

First Human Cell Experiments With FLASH Carbon Ions.

Tashiro M, Yoshida Y, Oike T, Nakao M, Yusa K, Hirota Y, Ohno T. Tashiro M, et al. Among authors: hirota y. Anticancer Res. 2022 May;42(5):2469-2477. doi: 10.21873/anticanres.15725. Anticancer Res. 2022. PMID: 35489744

10

Radiosensitization by the Selective Pan-FGFR Inhibitor LY2874455.

Darwis NDM, Horigome E, Li S, Adachi A, Oike T, Shibata A, Hirota Y, Ohno T. Darwis NDM, et al. Among authors: hirota y. Cells. 2022 May 24;11(11):1727. doi: 10.3390/cells11111727. Cells. 2022. PMID: 35681425 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,541 results

Search Page